--- title: "MediciNova (MNOV) stock listing, news and investor profile" url: "https://aibio.space/companies/medicinova/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "MediciNova, Inc. (NASDAQ: MNOV), United States. The directory classifies it as Pharmaceuticals: Major." --- MNOV MediciNova, Inc. NASDAQ · United States # MediciNova (MNOV) news Top story · Sep 28, 2026 · SEC filing 8-K ## [MediciNova signs a material agreement](https://www.sec.gov/Archives/edgar/data/1226616/000119312526405318/d120345d8k.htm) (the “Company”) amended its Lease (the “Lease”), dated July 20, 2021, between the Company and the Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026 (the “Amendment”), by and between the Company and Newport Gateway Office LLC. Source: [8-K filed Sep 28, 2026 on SEC EDGAR](https://www.sec.gov/Archives/edgar/data/1226616/000119312526405318/d120345d8k.htm) ## Latest MediciNova news We have not published a story on MediciNova yet. When there is news, it will appear here. ## MediciNova at a glance - **Ticker**: MNOV - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $25.4 million ### Related companies - [Matinas Biopharma Holdings](https://aibio.space/companies/matinas-biopharma/) AMEX: MTNB - [Gossamer Bio](https://aibio.space/companies/gossamer-bio/) NASDAQ: GOSS - [Spyre Therapeutics](https://aibio.space/companies/spyre-therapeutics/) NASDAQ: SYRE - [Ligand Pharmaceuticals](https://aibio.space/companies/ligand-pharmaceuticals/) NASDAQ: LGND - [Aprea Therapeutics](https://aibio.space/companies/aprea-therapeutics/) NASDAQ: APRE - [BlossomHill Therapeutics](https://aibio.space/companies/blossomhill-therapeutics/) NASDAQ: BLSM - [Evommune](https://aibio.space/companies/evommune/) NYSE: EVMN - [ABVC BioPharma](https://aibio.space/companies/abvc-biopharma/) NASDAQ: ABVC ### Also on NASDAQ - [Cronos Group](https://aibio.space/companies/cronos/) CRON - [NOMAD POWER SOLUTIONS, INC.](https://aibio.space/companies/nomad-power-solutions/) NMAD - [Corvus Pharmaceuticals](https://aibio.space/companies/corvus-pharmaceuticals/) CRVS - [Immunome](https://aibio.space/companies/immunome/) IMNM - [Coya Therapeutics](https://aibio.space/companies/coya-therapeutics/) COYA - [Karyopharm Therapeutics](https://aibio.space/companies/karyopharm-therapeutics/) KPTI ## MediciNova annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$6.7 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | [$6.8 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | | Net income (loss) | [-$12.0 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | [-$11.0 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | | Cash from operations | [-$9.8 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | [-$10.6 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | | Cash and equivalents | [$30.8 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526349323/) | [$40.4 million](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $25.4 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about MediciNova What is the ticker symbol of MediciNova? MediciNova, Inc. trades under the ticker MNOV on NASDAQ. Where is MediciNova listed? MediciNova, Inc. is listed on NASDAQ. Our directory also records these other listings: TSE:4875. What is the SEC CIK of MediciNova? The SEC Central Index Key (CIK) for MediciNova, Inc. is 1226616. Its filings are on SEC EDGAR. How many shares does MediciNova have outstanding? 49,221,246 shares as of 2026-08-11, per the cover page of its 10-Q filed 2026-08-13. Which country or territory is MediciNova listed under? Our directory records MediciNova, Inc. under United States. What does MediciNova do? Our directory classifies MediciNova, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of MediciNova? The ISIN recorded for MediciNova, Inc. is US58468P2065. Does aibio.space cover MediciNova? aibio.space lists MediciNova, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is MediciNova incorporated? SEC records list its state or country of incorporation as DE. Is MediciNova profitable? MediciNova, Inc. reported a net loss of $12.0 million for the fiscal year ended Dec 31, 2025, and used $9.8 million of cash in operations, per its annual report to the SEC. How much does MediciNova spend on research and development? $6.7 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does MediciNova have? $25.4 million in cash at Jun 30, 2026, per its 10-Q. What is MediciNova's market cap? We do not publish live share prices. In its annual report, MediciNova, Inc. put the market value of shares held by non-affiliates (public float) at $62.4 million as of Jun 30, 2025. Is MediciNova a smaller reporting company? SEC records list MediciNova, Inc.'s filer category as: Non-accelerated filer
Smaller reporting company. Where is MediciNova headquartered? SEC records list its business address as 4275 EXECUTIVE SQUARE, LA JOLLA, CA, 92037. ## Investor discussion: MediciNova Members talk about MediciNova (MNOV). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at MediciNova, newest first. Each line links the filing it comes from. 1. 2026-09-02 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02). [Source](https://www.sec.gov/Archives/edgar/data/1226616/000119312526379348/d159517d8k.htm) 2. 2025-12-30 Financings Reported a financing. SEC Form 8-K (Items 1.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1226616/000119312525335917/d25180d8k.htm) 3. 2025-12-05 Financings Set up an at-the-market program to sell shares over time. SEC Form S-3. [Source](https://www.sec.gov/Archives/edgar/data/1226616/000119312525309730/d17865ds3.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:MNOV on TradingView](https://www.tradingview.com/symbols/NASDAQ-MNOV/). ## SEC filings and registration - **SEC name**: Medicinova Inc - **CIK**: 1226616 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: MNOV (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 4275 EXECUTIVE SQUARE, LA JOLLA, CA, 92037 - **Phone**: 858-373-1500 - **Shares outstanding**: 49,221,246 as of 2026-08-11 (10-Q filed 2026-08-13) ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1226616/000119312526405318/d120345d8k.htm) filed 2026-09-28 - [8-K](https://www.sec.gov/Archives/edgar/data/1226616/000119312526379348/d159517d8k.htm) filed 2026-09-02 - [8-K](https://www.sec.gov/Archives/edgar/data/1226616/000119312526356146/d407050d8k.htm) filed 2026-08-19 - [10-Q](https://www.sec.gov/Archives/edgar/data/1226616/000119312526349323/mnov-20260630.htm) filed 2026-08-13 - [8-K](https://www.sec.gov/Archives/edgar/data/1226616/000119312526281171/mnov-20260623.htm) filed 2026-06-24 - [10-Q](https://www.sec.gov/Archives/edgar/data/1226616/000119312526224066/mnov-20260331.htm) filed 2026-05-14 - [DEF 14A](https://www.sec.gov/Archives/edgar/data/1226616/000119312526191866/mnov-20260429.htm) filed 2026-04-29 - [10-K](https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/mnov-20251231.htm) filed 2026-03-10 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001226616), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details MediciNova, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MNOV, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: MediciNova, Inc. - **Ticker**: MNOV - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US58468P2065 - **Other listed symbols**: TSE:4875 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-MNOV/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/medicinova/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "MediciNova (MNOV) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/medicinova/